Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study
In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any Euro...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Smyth, Emily Nash [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
16 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles - Zhou, Lixiao ELSEVIER, 2022, the international journal of drug therapy, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:37 ; year:2015 ; number:6 ; day:1 ; month:06 ; pages:1301-1316 ; extent:16 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clinthera.2015.03.016 |
|---|
| Katalog-ID: |
ELV018249159 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV018249159 | ||
| 003 | DE-627 | ||
| 005 | 20230623142632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinthera.2015.03.016 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015004000018.pica |
| 035 | |a (DE-627)ELV018249159 | ||
| 035 | |a (ELSEVIER)S0149-2918(15)00154-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |a 610 |a 600 |q VZ |
| 084 | |a 30.00 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Smyth, Emily Nash |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| 264 | 1 | |c 2015 | |
| 300 | |a 16 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. | ||
| 650 | 7 | |a retrospective studies |2 Elsevier | |
| 650 | 7 | |a pancreatic adenocarcinoma |2 Elsevier | |
| 650 | 7 | |a health resources |2 Elsevier | |
| 650 | 7 | |a outcomes assessment |2 Elsevier | |
| 650 | 7 | |a chemotherapy |2 Elsevier | |
| 700 | 1 | |a Bapat, Bela |4 oth | |
| 700 | 1 | |a Ball, Daniel E. |4 oth | |
| 700 | 1 | |a André, Thierry |4 oth | |
| 700 | 1 | |a Kaye, James A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Zhou, Lixiao ELSEVIER |t Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |d 2022 |d the international journal of drug therapy |g Amsterdam [u.a.] |w (DE-627)ELV007757921 |
| 773 | 1 | 8 | |g volume:37 |g year:2015 |g number:6 |g day:1 |g month:06 |g pages:1301-1316 |g extent:16 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clinthera.2015.03.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 30.00 |j Naturwissenschaften allgemein: Allgemeines |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 37 |j 2015 |e 6 |b 1 |c 0601 |h 1301-1316 |g 16 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
e n s en ens |
|---|---|
| matchkey_str |
smythemilynashbapatbelaballdanieleandrth:2015----:eattcacetcdncrioaramnptenhatcrrsucuenotoeifacadhuieknd |
| hierarchy_sort_str |
2015 |
| bklnumber |
30.00 44.13 |
| publishDate |
2015 |
| allfields |
10.1016/j.clinthera.2015.03.016 doi GBVA2015004000018.pica (DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Smyth, Emily Nash verfasserin aut Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study 2015 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier Bapat, Bela oth Ball, Daniel E. oth André, Thierry oth Kaye, James A. oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 https://doi.org/10.1016/j.clinthera.2015.03.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 6 1 0601 1301-1316 16 045F 610 |
| spelling |
10.1016/j.clinthera.2015.03.016 doi GBVA2015004000018.pica (DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Smyth, Emily Nash verfasserin aut Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study 2015 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier Bapat, Bela oth Ball, Daniel E. oth André, Thierry oth Kaye, James A. oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 https://doi.org/10.1016/j.clinthera.2015.03.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 6 1 0601 1301-1316 16 045F 610 |
| allfields_unstemmed |
10.1016/j.clinthera.2015.03.016 doi GBVA2015004000018.pica (DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Smyth, Emily Nash verfasserin aut Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study 2015 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier Bapat, Bela oth Ball, Daniel E. oth André, Thierry oth Kaye, James A. oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 https://doi.org/10.1016/j.clinthera.2015.03.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 6 1 0601 1301-1316 16 045F 610 |
| allfieldsGer |
10.1016/j.clinthera.2015.03.016 doi GBVA2015004000018.pica (DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Smyth, Emily Nash verfasserin aut Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study 2015 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier Bapat, Bela oth Ball, Daniel E. oth André, Thierry oth Kaye, James A. oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 https://doi.org/10.1016/j.clinthera.2015.03.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 6 1 0601 1301-1316 16 045F 610 |
| allfieldsSound |
10.1016/j.clinthera.2015.03.016 doi GBVA2015004000018.pica (DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Smyth, Emily Nash verfasserin aut Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study 2015 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier Bapat, Bela oth Ball, Daniel E. oth André, Thierry oth Kaye, James A. oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 https://doi.org/10.1016/j.clinthera.2015.03.016 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 6 1 0601 1301-1316 16 045F 610 |
| language |
English |
| source |
Enthalten in Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles Amsterdam [u.a.] volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 |
| sourceStr |
Enthalten in Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles Amsterdam [u.a.] volume:37 year:2015 number:6 day:1 month:06 pages:1301-1316 extent:16 |
| format_phy_str_mv |
Article |
| bklname |
Naturwissenschaften allgemein: Allgemeines Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
retrospective studies pancreatic adenocarcinoma health resources outcomes assessment chemotherapy |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| authorswithroles_txt_mv |
Smyth, Emily Nash @@aut@@ Bapat, Bela @@oth@@ Ball, Daniel E. @@oth@@ André, Thierry @@oth@@ Kaye, James A. @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007757921 |
| dewey-sort |
3610 |
| id |
ELV018249159 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018249159</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623142632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinthera.2015.03.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018249159</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-2918(15)00154-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Smyth, Emily Nash</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">16</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">retrospective studies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pancreatic adenocarcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">health resources</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">outcomes assessment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bapat, Bela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ball, Daniel E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">André, Thierry</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaye, James A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhou, Lixiao ELSEVIER</subfield><subfield code="t">Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles</subfield><subfield code="d">2022</subfield><subfield code="d">the international journal of drug therapy</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007757921</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:6</subfield><subfield code="g">day:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:1301-1316</subfield><subfield code="g">extent:16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinthera.2015.03.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2015</subfield><subfield code="e">6</subfield><subfield code="b">1</subfield><subfield code="c">0601</subfield><subfield code="h">1301-1316</subfield><subfield code="g">16</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Smyth, Emily Nash |
| spellingShingle |
Smyth, Emily Nash ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| authorStr |
Smyth, Emily Nash |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007757921 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy Elsevier |
| topic |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy |
| topic_unstemmed |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy |
| topic_browse |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier retrospective studies Elsevier pancreatic adenocarcinoma Elsevier health resources Elsevier outcomes assessment Elsevier chemotherapy |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
b b bb d e b de deb t a ta j a k ja jak |
| hierarchy_parent_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| hierarchy_parent_id |
ELV007757921 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction 600 - Technology |
| hierarchy_top_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007757921 |
| title |
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| ctrlnum |
(DE-627)ELV018249159 (ELSEVIER)S0149-2918(15)00154-X |
| title_full |
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| author_sort |
Smyth, Emily Nash |
| journal |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| journalStr |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
1301 |
| author_browse |
Smyth, Emily Nash |
| container_volume |
37 |
| physical |
16 |
| class |
610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Smyth, Emily Nash |
| doi_str_mv |
10.1016/j.clinthera.2015.03.016 |
| dewey-full |
610 690 600 |
| title_sort |
metastatic pancreatic adenocarcinoma treatment patterns, health care resource use, and outcomes in france and the united kingdom between 2009 and 2012: a retrospective study |
| title_auth |
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| abstract |
In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. |
| abstractGer |
In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. |
| abstract_unstemmed |
In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
6 |
| title_short |
Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study |
| url |
https://doi.org/10.1016/j.clinthera.2015.03.016 |
| remote_bool |
true |
| author2 |
Bapat, Bela Ball, Daniel E. André, Thierry Kaye, James A. |
| author2Str |
Bapat, Bela Ball, Daniel E. André, Thierry Kaye, James A. |
| ppnlink |
ELV007757921 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.clinthera.2015.03.016 |
| up_date |
2024-07-06T18:22:47.394Z |
| _version_ |
1803854982567428096 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018249159</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623142632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinthera.2015.03.016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018249159</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-2918(15)00154-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Smyth, Emily Nash</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metastatic Pancreatic Adenocarcinoma Treatment Patterns, Health Care Resource Use, and Outcomes in France and the United Kingdom Between 2009 and 2012: A Retrospective Study</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">16</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In Europe, pancreatic cancer (PC) accounts for approximately 2.6% of all new cancer cases and is the fourth leading cause of cancer-related death. Despite substantial morbidity and mortality, limited data are available describing real-world treatment patterns and health care resource use in any European country. We evaluated PC-related treatment patterns and associated health care resource use among patients with metastatic PC in the United Kingdom and France.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">retrospective studies</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pancreatic adenocarcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">health resources</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">outcomes assessment</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">chemotherapy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bapat, Bela</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ball, Daniel E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">André, Thierry</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaye, James A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhou, Lixiao ELSEVIER</subfield><subfield code="t">Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles</subfield><subfield code="d">2022</subfield><subfield code="d">the international journal of drug therapy</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007757921</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:6</subfield><subfield code="g">day:1</subfield><subfield code="g">month:06</subfield><subfield code="g">pages:1301-1316</subfield><subfield code="g">extent:16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinthera.2015.03.016</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2015</subfield><subfield code="e">6</subfield><subfield code="b">1</subfield><subfield code="c">0601</subfield><subfield code="h">1301-1316</subfield><subfield code="g">16</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400339 |